Member Info for Kaneonaim

As a spurs fan would be great to see him on the Arsenal Board!!!!!

This will shoot up to the moon when it comes!!! Heard that somewhere before??

Definitely not to get on that plane!!!

A well worked sell?? If ever there was one???

You got it!!! PMSL

The Chinese water deer appears to be particularly sensitive to environmental changes, and agriculture and urban development are major threats to its habitat. The species has been lost from much of its original range, and its distribution is continuing to shrink, with many populations now being quite small and fragmented.

As its name suggests, the Chinese water deer typically lives in marshy habitats, and it is an adept swimmer.

Guys??? Chinese water deer’s???

In all seriousness Have you seen those Chinese water deers??? Would not want to mess with one of them!!!!!

The majority of patients had an improvement in PSA doubling time on study ▪ One patient (4mg/kg) with metastatic castrate resistant prostate cancer had a >40% PSA response. ▪ Subjects on 5mg/kg analysis not yet completed – showing tolerability and modulation of related factors and a >40-50% PSA reduction suggested ▪ Subject on intra patent escalation still in dosing phase no verified data so far except for basic safety and tolerability being observed. First SAE (SUSAR) in one subject with a hypertensive history . However, PSA stabilisation and other related APC factors are being seen to moderate under the influence of VAL201 PK and PD analysis for all dose levels continuing and ongoing. Initial observations - clinical results correlate with pre- clinical model systems and projections Think we could be in for a mighty RNS Wouldn’t want to be out of this over the weekend!!!!!!

Wouldn’t want to be out of this over the weekend?

The recent achievements and progress with all projects have clearly generated asset value and been of benefit to patients Lung Cancer Clinical trial of VAL401 • Positive data shows increased survival and quality of life • Results from the initial trial are informing the design of a Phase 3 pivotal trial, • Expected regulatory filings have been made during 2018 • Peer review publication of the successful outcome accepted 1st Q 2019 expected publication • Deciding the best way for the next stage trial and commercial activity with partners 2019 Prostate Cancer Clinical Trial for VAL201 • Compelling early clinical data in late stage prostate cancer • Enhanced design of study to see further and heightened therapeutic effects • Trial completing final date 2019 reporting thereafter. • Explore other potential indications with partners 2019 • The next and hopefully pivotal trial in planning with partners. Late 2019 Taken from presentation- 2019 might just be the one!!!!!! LOL!!!!!

Secret WhatsApp group lol

Just fed up !!!! Thought I’d add my opinion

Didn’t have one

Was valju mentioned that date from a WhatsApp group or something??

I’m not too far behind!!!!

Guess 9p off the table now!!!!

All before 9:30

No need for personal remarks bang out of order!!!!!!